RU
UA
Modern medicine is undergoing a fundamental shift from symptomatic treatment to biological reconstruction of tissues and organs. At the center of this transformation is stem cell therapy — a field that over the past 20 years has evolved from an experimental concept into one of the most dynamically developing areas of biomedicine.
If traditional pharmacology acts on biochemical pathways of disease, regenerative medicine seeks to influence the structure of the tissue itself, restoring its architecture, cellular composition, and functional properties.
Today, the term “stem cell therapy” hides not a single technology, but an entire ecosystem of approaches:
cell therapy (MSC, ADSC, BMSC)
induced pluripotent stem cells (iPSC)
lineage-committed progenitor cells
secretome therapy (exosomes, extracellular vesicles)
tissue bioengineering and 3D bioprinting
molecular regulation through miRNA and growth factors
This convergence of biology, engineering, and computational technologies forms a new discipline — precision regenerative medicine.
Biological basis: why stem cells became a revolution
Stem cells possess unique biological plasticity. Their key feature lies not only in their ability to differentiate, but also in their powerful regulatory function through paracrine signals.
Modern studies show that the main therapeutic effectiveness of most MSC populations is not related to their integration into tissues, but to the release of biologically active secretome, which includes:
exosomes and microRNA
cytokines (IL-10, TGF-β, IL-6)
growth factors (VEGF, FGF, PDGF)
lipid signaling molecules
antioxidant enzymes
Thus, a stem cell is not a “building block”, but a biological signaling system that reprograms the local tissue microenvironment.
MSC and ADSC: the first wave of regenerative medicine
Mesenchymal stem cells (MSC), including bone marrow cells and adipose tissue cells (ADSC), became the first clinically significant platform of regenerative therapy.
ADSC are especially important due to:
high availability of the tissue source
high proliferative activity
stable secretome profile
pronounced immunomodulatory effect
However, even these cells represent only the first generation of regenerative biology, as their differentiation potential is limited to mesodermal lineages.
iPSC revolution: reprogramming cellular identity
The real breakthrough occurred with the discovery of induced pluripotent stem cells (iPSC), first described by Shinya Yamanaka.
iPSC allow somatic cells to be reprogrammed back into an embryonic-like state without the use of embryonic material.
This changed the entire architecture of regenerative medicine.
Key properties of iPSC:
pluripotency (differentiation into any tissue)
ability to create personalized cell lines
in vitro disease modeling
potential creation of “patient-specific organs”
iPSC are today used not only for therapy, but also for creating:
cardiomyocytes
neurons
hepatocytes
pancreatic beta cells
Lineage-committed progenitor cells: precision instead of universality
If iPSC are a “universal building material”, then progenitor cells are specialized construction teams.
Committed cells are already on the path of differentiation and have a number of advantages:
higher safety (lower tumorigenicity risk)
predictable behavior
rapid integration into tissue
directed functionality
For example:
endothelial progenitors → vascular regeneration
neural progenitors → CNS repair
myogenic progenitors → muscle reconstruction
Secretome and exosomes: a new “language system” of cells
One of the most important discoveries in recent years was the understanding that the therapeutic effect of stem cells is realized through the secretome.
The secretome is the totality of all biologically active molecules released by a cell.
Of particular importance are exosomes — nanoparticles 30–150 nm in size that carry:
microRNA
mRNA
regulatory proteins
lipid mediators
Exosomes act as an intercellular communication system, allowing one cell to “reprogram” another without direct contact.
Functional molecules: biochemical engineering of repair
Modern regenerative medicine is increasingly shifting from cells to molecules.
Key classes of functional molecules:
1. Growth factors
VEGF (angiogenesis)
FGF (proliferation)
PDGF (tissue remodeling)
2. Cytokines
IL-10 (anti-inflammatory effect)
TNF-α modulation
3. microRNA
gene expression regulation
fibrosis suppression
cell cycle control
4. Extracellular vesicles
signal delivery
tissue coordination
Thus, modern therapy becomes a molecularly programmable system of tissue restoration.
3D bioprinting and organoids: engineering living tissues
One of the most revolutionary directions is 3D bioprinting.
This technology allows the creation of:
layered tissue structures
vascular networks
organoids (mini-organs)
It is based on a combination of:
bioinks (hydrogel scaffolds)
living cells (MSC, iPSC, progenitors)
growth factors
Examples of application:
skin for transplantation
cartilage structures
experimental models of the heart and liver
vascular networks
Organoids are especially important for:
drug testing
disease modeling
personalized medicine
Integration of technologies: from cell to system
Modern regenerative medicine no longer uses a single approach.
It develops as an integrated system:
iPSC → source of universal cells
progenitors → functional modules
MSC/ADSC → immunomodulation
exosomes → signaling coordination
growth factors → activation of regeneration
3D bioprinting → structural organization
This forms the concept:
“regenerative ecosystem medicine”
Clinical limitations and challenges
Despite progress, key limitations remain:
lack of long-term clinical data
variability of cell products
absence of global standardization
difficulty of scaling iPSC technologies
regulatory barriers
Future: where stem cell therapy is heading
The next 10–20 years will likely define a new medical era.
Main trends:
personalized iPSC organs
cell-free therapy (exosome-based medicine)
genetically modified MSC
AI design of regenerative molecules
3D printing of functional organs
Conclusion
Stem cell therapy is no longer a narrow medical field. It is becoming a universal platform for the restoration of biological systems.
The combination of cell biology, molecular engineering, and 3D technologies forms a new medical reality in which damaged tissues can not only be treated but also biologically recreated.
The future of medicine is not disease treatment, but restoration of the integrity of a living system.
" alt="loading" class="img-responsive"/>
" alt="loading" class="img-responsive"/>
" alt="loading" class="img-responsive"/>